低血糖作为疑似免疫检查点抑制剂诱发的1型糖尿病的首发表现。
Hypoglycemia as first presentation of presumed immune checkpoint inhibitor-induced type 1 diabetes.
作者信息
Kamal Rayyan Syed, Dean Arleigh, Dutt Hanna, Rajeh Adnan, Fernandes Ricardo
机构信息
Schulich School of Medicine and Dentistry Western University London Ontario Canada.
Cancer Research Laboratory Program, Lawson Health Research Institute London Health Sciences Centre London Ontario Canada.
出版信息
Clin Case Rep. 2023 Sep 7;11(9):e7897. doi: 10.1002/ccr3.7897. eCollection 2023 Sep.
Abstract
We present a case of a 60-year-old male diagnosed with metastatic clear cell renal cell carcinoma who developed hypoglycemia during induction ipilimumab and nivolumab treatment. This was diagnosed as presumed type 1 diabetes mellitus secondary to immunotherapy.
摘要
我们报告一例60岁男性，诊断为转移性透明细胞肾细胞癌，在诱导使用伊匹木单抗和纳武单抗治疗期间出现低血糖。这被诊断为继发于免疫治疗的疑似1型糖尿病。
Zotero 插件